Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Mydecine Innovations Group Inc (MYCO.CN)

Mydecine Innovations Group Inc (MYCO.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 74,871
  • Shares Outstanding, K 162,763
  • Annual Sales, $ 126 K
  • Annual Income, $ -3,508 K
  • 60-Month Beta 3.49
  • Price/Sales 1,088.43
  • Price/Cash Flow N/A
  • Price/Book 7.52
Trade MYCO.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.11
  • Most Recent Earnings -0.08 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.345 +15.94%
on 03/05/21
0.530 -24.53%
on 02/25/21
-0.100 (-20.00%)
since 02/24/21
3-Month
0.345 +15.94%
on 03/05/21
0.650 -38.46%
on 02/16/21
-0.070 (-14.89%)
since 12/24/20
52-Week
0.060 +566.67%
on 03/26/20
1.150 -65.22%
on 06/08/20
+0.330 (+471.43%)
since 03/24/20

Most Recent Stories

More News
Telehealth Boom Is Driving this Mental Health Company’s Progress

FN Media Group Presents Microsmallcap.com Market Commentary

TDOC : 30.31 (-3.56%)
HIMS : 7.84 (-0.63%)
WELL.TO : 3.67 (-2.39%)
WLYYF : 4.1600 (+3.74%)
DOC.VN : 0.205 (-2.38%)
DOCRF : 0.1580 (-0.82%)
MYCO.CN : 0.400 (-6.98%)
MYCOF : 0.4500 (unch)
Mycology Interest on the Rise as Researchers Unearth More Benefits of Functional Mushroom Products

FN Media Group Presents USA News Group News Commentary

CYBN.NE : 0.6000 (+3.45%)
PSYCF : 0.0600 (+4.53%)
PULL.CN : 0.0100 (unch)
PRXTF : 0.0091 (-1.09%)
CYBN : 0.4400 (unch)
CLXPF : 3.0200 (-1.31%)
TRUFF : 0.0903 (+5.00%)
TRIP.CN : 0.1300 (+4.00%)
MYCOF : 0.4500 (unch)
MYCO.CN : 0.400 (-6.98%)
PSYC.CN : 0.0800 (unch)
Mydecine Innovations Group Announces Migration to NEO Exchange

Trading will commence on the NEO under the ticker symbol “MYCO” today, March 23, 2021

MYCO.CN : 0.400 (-6.98%)
MYCO.NE : 0.5500 (-6.78%)
MYCOF : 0.4500 (unch)
Psychedelics Becoming Valuable Alternatives to Conventional Mental Health Treatments

FN Media Group Presents Microsmallcap.com Market Commentary

MYCO.CN : 0.400 (-6.98%)
MYCOF : 0.4500 (unch)
PFE : 43.76 (-0.68%)
LLY : 337.66 (-0.42%)
CMPS : 10.25 (-0.29%)
JNJ : 163.36 (-0.76%)
Psychedelic Drugs Market Ballooning Quickly Due to Increasing Frequency of Mental Disorders

Palm Beach, FL – March 19, 2021 – Psychedelic Medicines also called as hallucinogenics, are a group of substances including chemicals, such as LSD, and plants that are used in the treatment of various...

MMED.NE : 5.4100 (+15.85%)
MCUR.CN : 0.075 (+36.36%)
MCURF : 0.0450 (-10.00%)
LKYSF : 0.4800 (-3.63%)
NUMI.VN : 0.580 (+9.43%)
MYCOF : 0.4500 (unch)
MYCO.CN : 0.400 (-6.98%)
CMPS : 10.25 (-0.29%)
MMEDF : 4.6900 (+33.24%)
Mydecine Innovations Group Provides Update on European Operations

Company Appoints Former Novartis Norway CEO as President of European Operations, and Partners with Dr. David Erritzoe in the set up of a novel collaborative psychopharmacology/psychedelic research clinic...

MYCO.CN : 0.400 (-6.98%)
MYCOF : 0.4500 (unch)
Mydecine Announces Change of Auditor

Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), announces that the board of directors of the Company has appointed MNP LLP, Chartered Professional...

MYCO.CN : 0.400 (-6.98%)
MYCOF : 0.4500 (unch)
Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

*NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

MYCO.CN : 0.400 (-6.98%)
MYCOF : 0.4500 (unch)
Telehealth Likely to Continue Growing Long After the Public Health Crisis

FN Media Group Presents Microsmallcap.com Market Commentary

MYCO.CN : 0.400 (-6.98%)
MYCOF : 0.4500 (unch)
TDOC : 30.31 (-3.56%)
ONEM : 14.97 (-2.09%)
AMWL : 3.83 (-4.96%)
CVS : 85.25 (-0.61%)
Mydecine Fully Completes the First-Ever International Export of Psilocybin Mushrooms and Solidifies its Clinical and Commercial Supply Chain

DENVER, March 01, 2021 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma company in the life sciences category...

MYCO.CN : 0.400 (-6.98%)
MYCOF : 0.4500 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.487
2nd Resistance Point 0.463
1st Resistance Point 0.432
Last Price 0.400
1st Support Level 0.377
2nd Support Level 0.353
3rd Support Level 0.322

See More

52-Week High 1.150
Fibonacci 61.8% 0.734
Fibonacci 50% 0.605
Fibonacci 38.2% 0.476
Last Price 0.400
52-Week Low 0.060

See More

Business Summary

Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses:...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar